HomeCRVS • NASDAQ
Corvus Pharmaceuticals Inc
add
$4.63
5.95%
After Hours:(0.00%)0.00
$4.63
Closed: Mar 12, 4:01:41 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.26M | 30.49% |
Net income | -40.22M | -570.28% |
Net profit margin | — | — |
Earnings per share | -0.60 | -400.00% |
EBITDA | -7.23M | -30.81% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.65M | 29.48% |
Total assets | 58.82M | 13.23% |
Total liabilities | 46.41M | 506.38% |
Total equity | 12.41M | — |
Shares outstanding | 64.26M | — |
Price to book | 21.85 | — |
Return on assets | -29.40% | — |
Return on capital | -56.08% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -40.22M | -570.28% |
Cash from operations | -6.32M | -16.32% |
Cash from investing | -3.89M | -122.17% |
Cash from financing | 50.00K | -85.07% |
Net change in cash | -10.16M | -181.63% |
Free cash flow | 29.38M | 932.73% |
Previous close
$4.37
Day range
$4.33 - $4.71
Year range
$1.30 - $10.00
Market cap
297.51M USD
Avg Volume
556.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
28
